Ambio Life Sciences News Today

VANCOUVER, BC, May 20, 2024 /PRNewswire/ - Today, Terragnosis Inc., a Canadian drug development company, announced IBEX011, the first GMP extract of Tabernanthe iboga available for use in ibogaine clinics

/PRNewswire/ - Today, Terragnosis Inc., a Canadian drug development company, announced IBEX011, the first GMP extract of Tabernanthe iboga available for use in...

Researchers have discovered that the plant-based psychoactive drug ibogaine can safely and effectively reduces PTSD, anxiety and depression.

Ibogaine, derived from a central African shrub, has been used in rituals for two millennia. But in a small study, it appeared to reduce symptoms of PTSD among veterans

On average, treatment with ibogaine immediately led to significant improvements in functioning, PTSD, depression, and anxiety – and those effects persisted until at least one month after treatment. 

For military veterans, many of the deepest wounds of war are invisible: Traumatic brain injuries resulting from head trauma or blast explosions are a leading cause of post-traumatic stress disorder, anxiety, depression and suicide among veterans.

California researchers say just one dose of ibogaine administered orally eased mental health problems in 30 US veterans - whose symptoms did not return one month after treatment.

The significant impact of ibogaine on TBI indicates its potential as a broader therapeutic option for various neuropsychiatric conditions.

In combat veterans, a single dose of ibogaine also improved symptoms of PTSD, depression and anxiety

The study by Stanford researchers is the first to explore the use of the psychedelic ibogaine to repair traumatic brain injury.